James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.

Although the vast majority of nodules are benign, many are referred for biopsy as a precaution to rule out malignancy.

The duo announced the partnership on Monday, stating that the collaboration marks “a shift in how healthcare institutions approach data.” 

New data suggest the model outperforms publicly available segmentation algorithms.  

The product was developed to both improve image quality and shorten image acquisition times. 

The use of DLR also provides greater flexibility with protocols in comparison to conventional single-shot echo-planar imaging.

Rates of colorectal cancer are on the rise, most notably in younger adults, who have seen CRC diagnoses double over the last decade.

Though numerous web-based tools have been created to flag published works that appear suspicious for AI authorship, the performances of these tools has been inconsistent thus far.